• Home
  • NEW DAY MEDICINE
  • 2(40)2022
  • 99 -2 (40) 2022 — Baratova Mehriban Subidinovna — DIAGNOSTICS OF CORONAVIRAL INFECTION IN CARDIOVASCULAR PATHOLOGY

99 -2 (40) 2022 — Baratova Mehriban Subidinovna — DIAGNOSTICS OF CORONAVIRAL INFECTION IN CARDIOVASCULAR PATHOLOGY

DIAGNOSTICS OF CORONAVIRAL INFECTION IN CARDIOVASCULAR PATHOLOGY

Baratova Mehriban Subidinovna Bukhara State Medical Institute

Resume

The article is devoted to the current problem of coronavirus infection. This viral infection is often relatively easy to carry, but a high risk of complications is typical for some population groups (the elderly, people with chronic diseases, weakened immunity and often patients who have cardiovascular diseases). COVID-19 Conducting bedside echocardiography is diagnostically significant if myocarditis is suspected, as one of the manifestations of heart damage in coronavirus infection. Quarantine and other public health methods are effective and valuable ways to combat infectious disease and public anxiety.  Isolation is that their careful use will delay rather than prevent the spread of infection between communities and can reduce the stress limit and thus buy valuable time to implement other control methods.

Key words: coronavirus infection, cardiovascular system, echocardiography, ultrasound, myocarditis, epidemic, quarantine

First pae

502

Last page

507

For citation: Baratova Mehriban Subidinovna DIAGNOSTICS OF CORONAVIRAL INFECTION IN CARDIOVASCULAR PATHOLOGY//New Day in Medicine 2(40)2022 502-507 https://clck.ru/eSSjK

LIST OF REFERENCES:

  1. “Product Information. Fortovase (saquinavir)” Roche Laboratories, Nutley, N.J.
  2. “Product Information. Xarelto (rivaroxaban).” Bayer Inc, Toronto, IA.
  3. Баутин А.Е., Мазурок В.А., Осовских В.В., Афанасьева К.Ю. Гемодинамические эффекты маневра мобилизации альвеол у пациентов кардиохирургического профиля с систолической дисфункцией левого желудочка // Анестезиология и реаниматология. –  2014. –  Т. 59. № 6. –  С. 43-48.
  4. Временные методические рекомендации Минздрава России «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID–19)», версия 4 от 27.03.2020 .
  5. Мареев В.Ю. лекция на тему: «COVID-19 и сердечно-сосудистые заболевания: вопросы диагностики и лечения». 14.04.2020 https://www.youtube.com/watch?v=Fe8MN_P_yCQ&feature=share&fbclid=IwAR1ob5ff33d60hMLm_f3WObt2tsf7QuUK5EqSfXd_7norN49s2KOX8sJXY
  6. Шляхто Е. В., Конради А. О. Виллевальде С. В., Звартау Н. Э., Яковлев А. Н. И др.// Руководство по диагностике и лечению болезней системы кровообращения (БСК) в контексте пандемии COVID-19 //2020,С.41.
  7. A statement          from     the       International      Society             of  Hypertension on COVID-19.            https://ishworld.com/news/a/A–statement–from–the–International–Society–of–Hypertension–on–COVID–19// Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med 2016; 36:78-80.
  8. Alon D., Stein G.Y., Korenfeld R., Fuchs S. Predictors and outcomes of infection-related hospital admissions of heart failure patients. PLoS One 2013;8:e72476.
  9. WHO Director-General is opening remarks at the media briefing on COVID-19 [Published online 11 march 2020]. [Electronic resource]. URL: https://www.who.int/dg/speeches/ detail/who-director-general-s-openingremarks-at-the-media-briefing-on-covid-19-11-march-2020. Accessed March 19, 2020.
  10. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. doi:10.1016/S 0140-6736(20)30566-3
  11. Clerkin K.J., Fried J.A., Raikhelkar J., Sayer G., Griffin J.M., Masoumi A. et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation. 2020;141(20):1648-1655. doi.org/10.1161/CIRCULATIONAHA.120.046941
  12. Verity R., Okell L.C., Dorigatti I., Winskill P., Whittaker C., Imai N. et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020; 20(6):669-677. doi.org/10.1016/S 1473-3099(20)30243-7
  13. Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-260. doi.org/ 10.1038/s41569-020-0360
  14. Атоева М.А. Ограничительные меры во время эпидемий: исторический экскурс и проблемы настоящего времени. Монография, «BUXORO NASHR» 2020. 105 стр.
  15. Гендон Ю.З. Возможность предсказаний пандемии гриппа. //Журнал микробиологии. 2016; 3: 113–120.
  16. Яковлева Т.В., Брико Н.И., Герасимова А.Н. и др. Сравнительная характеристика эпидемических сезонов гриппа 2015–2016 и 2009–2010 гг. //Журнал микробиологии. 2017; 1: 11–19.
  17. Chan-Yeung M., Xu R.H. SARS: epidemiology. Respirology 2003; 8(suppl): 9– 14.
  18. Epidemiology, Virology, Clinical Characteristics, and Treatment strategy.//Clin. Chest. Med. 2017; 38:59–70.
  19. Baratova M.S., Atayeva M.A. Тhe estimation of heart rhythm disturbances at the left atrial stunding on early stages of remodeling left ventricular / World medicine journal no 1 (1) 2020.Р.272-286.
  20. Atayeva M.A. Cardiomyopathy as a Manifestation of Complications of Chronic Viral Hepatitis/ American Journal of Medicine and Medical Sciences

file

download